The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair

DNA Repair

Volumn 9, Issue 7, 2010, Pages 813-823

  Nguyen, Thuy Ai ^a   Slattery, Scott D ^a   Moon, Sung Hwan ^a   Darlington, Yolanda F ^a   Lu, Xiongbin ^a   Donehower, Lawrence A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CPD; Nucleotide excision repair; Phosphatase; Phosphorylation; PPM1D; WIP1

Indexed keywords

PHOSPHATASE; PYRIMIDINE DIMER; SERINE; THREONINE; UNCLASSIFIED DRUG; WILD TYPE P53 INDUCED PHOSPHATASE 1; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; EXCISION REPAIR; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; ULTRAVIOLET IRRADIATION;

ANIMALS; CELL LINE, TUMOR; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; ONCOGENES; PHOSPHOPROTEIN PHOSPHATASES; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

ATAXIA TELANGIECTASIA; MUS;

EID: 77953323484     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2010.04.005     Document Type: Article

References (50)

1. Gillet L.C.J., and Scharer O.D. Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem. Rev. 106 (2006) 253-276
2. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 1 (2001) 22-33
3. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
4. Lazzaro F., Giannattasio M., Puddu F., Granata M., Pellicioli A., Plevani P., and Muzi-Falconi M. Checkpoint mechanisms at the intersection between DNA damage and repair. DNA Repair (Amst.) 8 (2009) 1055-1067
5. Nouspikel T. DNA repair in mammalian cells: nucleotide excision repair: variations on versatility. Cell. Mol. Life Sci. 66 (2009) 994-1009
6. Cimprich K.A., and Cortez D. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell. Biol. 9 (2008) 616-627
7. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
8. Auclair Y., Rouget R., Affar e.B., and Drobetsky E.A. ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 17896-17901
9. Helton E.S., and Chen X. p53 modulation of the DNA damage response. J. Cell. Biochem. 100 (2007) 883-896
10. Smith M.L., and Seo Y.R. p53 regulation of DNA excision repair pathways. Mutagenesis 17 (2002) 149-156
11. Wu X., Shell S.M., Liu Y., and Zou Y. ATR-dependent checkpoint modulates XPA nuclear import in response to UV irradiation. Oncogene 26 (2007) 757-764
12. Wu X.M., Shell S.M., Yang Z.G., and Zou Y. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group a by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation. Cancer Res. 66 (2006) 2997-3005
13. Adimoolam S., and Ford J.M. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12985-12990
14. Hwang B.J., Ford J.M., Hanawalt P.C., and Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 424-428
15. Chang Y.C., Jan K.Y., Cheng C.A., Liao C.B., and Liu Y.C. Direct involvement of the tumor suppressor p53 in nucleotide excision repair. DNA Repair (Amst.) 7 (2008) 751-761
16. Fiscella M., Zhang H.L., Fan S.J., Sakaguchi K., Shen S.F., Mercer W.E., VandeWoude G.F., OConnor P.M., and Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6048-6053
17. Lu X., Nguyen T.A., Moon S.H., Darlington Y., Sommer M., and Donehower L.A. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metast. Rev. 27 (2008) 123-135
18. Lu X.B., Nannenga B., and Donehower L.A. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 19 (2005) 1162-1174
19. Shreeram S., Demidov O.N., Hee W.K., Yamaguchi H., Onishi N., Kek C., Timofeev O.N., Dudgeon C., Fornace A.J., Anderson C.W., Minami Y., Appella E., and Bulavin D.V. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol. Cell 23 (2006) 757-764
20. Fujimoto H., Onishi N., Kato N., Takekawa M., Xu X., Kosugi A., Kondo T., Imamura M., Oishi I., Yoda A., and Minami Y. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ. 13 (2006) 1170-1180
21. Oliva-Trastoy M., Berthonaud V., Chevalier A., Ducrot C., Marsolier-Kergoat M.C., Mann C., and Leteurtre F. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase. Oncogene 26 (2007) 1449-1458
22. Takekawa M., Adachi M., Nakahata A., Nakayama I., Itoh F., Tsukuda H., Taya Y., and Imai K. p53-inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19 (2000) 6517-6526
23. Lu X., Ma O., Nguyen T.A., Jones S.N., Oren M., and Donehower L.A. The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell 12 (2007) 342-354
24. Zhang X., Lin L., Guo H., Yang J., Jones S.N., Jochemsen A., and Lu X. Phosphorylation and degradation of MdmX is inhibited by Wip1 phosphatase in the DNA damage response. Cancer Res. 69 (2009) 7960-7968
25. Lu X.B., Bocangel D., Nannenga B., Yamaguchi H., Appella E., and Donehower L.A. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol. Cell 15 (2004) 621-634
26. Moon S.H., Lin L., Zhang X., Nguyen T.A., Darlington Y., Waldman A.S., Lu X., and Donehower L.A. Wildtype p53-induced phosphatase 1 dephosphorylates histone variant {gamma}-H2AX and suppresses DNA double strand break repair. J. Biol. Chem. (2010)
27. Lu X.B., Nguyen T.A., and Donehower L.A. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D. Cell Cycle 4 (2005) 1060-1064
28. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., and Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
29. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., DiTullio Jr. R.A., Kastrinakis N.G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., and Halazonetis T.D. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
30. Halazonetis T.D., Gorgoulis V.G., and Bartek J. An oncogene-induced DNA damage model for cancer development. Science 319 (2008) 1352-1355
31. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., Kallioniemi A., Fornace A.J., and Appella E. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31 (2002) 210-215
32. Li J., Yang Y., Peng Y., Austin R.J., van Eyndhoven G., Nguyen K.C.Q., Gabriele T., McCurrach M.E., Marks J.R., Hoey T., Lowe S.W., and Powers S. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat. Genet. 31 (2002) 133-134
33. Rauta J., Alarmo E.L., Kauraniemi P., Karhu R., Kuukasjarvi T., and Kallioniemi A. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res. Treatment 95 (2006) 257-263
34. Saito-Ohara F., Imoto I., Inoue J., Hosoi H., Nakagawara A., Sugimoto T., and Inazawa J. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res. 63 (2003) 1876-1883
35. Hirasawa A., Saito-Ohara F., Inoue J., Aoki D., Susumu N., Yokoyama T., Nozawa S., Inazawa J., and Imoto I. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets. Clin. Cancer Res. 9 (2003) 1995-2004
36. Tan D.S., Lambros M.B., Rayter S., Natrajan R., Vatcheva R., Gao Q., Marchio C., Geyer F.C., Savage K., Parry S., Fenwick K., Tamber N., Mackay A., Dexter T., Jameson C., McCluggage W.G., Williams A., Graham A., Faratian D., El Bahrawy M., Paige A.J., Gabra H., Gore M.E., Zvelebil M., Lord C.J., Kaye S.B., Ashworth A., and Reis-Filho J.S. PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin. Cancer Res. 15 (2009) 2269-2280
37. Nannenga B., Lu X.B., Dumble M., Van Maanen M., Nguyen T.A., Sutton R., Kumar T.R., and Donehower L.A. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice. Mol. Carcinog. 45 (2006) 594-604
38. Choi J., Nannenga B., Demidov O.N., Bulavin D.V., Cooney A., Brayton C., Zhang Y.X., Mbawuike I.N., Bradley A., Appella E., and Donehower L.A. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol. Cell. Biol. 22 (2002) 1094-1105
39. Yamaguchi H., Minopoli G., Demidov O.N., Chatterjee D.K., Anderson C.W., Durell S.R., and Appella E. Substrate specificity of the human protein phosphatase 2C delta Wip1. Biochemistry 44 (2005) 5285-5294
40. Johnson J.M., and Latimer J.J. Analysis of DNA repair using transfection-based host cell reactivation. Methods Mol. Biol. 291 (2005) 321-335
41. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z.M., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., and Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316 (2007) 1160-1166
42. Christmann M., Tomicic M.T., and Kaina B. Phosphorylation of mismatch repair proteins MSH2 and MSH6 affecting MutSalpha mismatch-binding activity. Nucleic Acids Res. 30 (2002) 1959-1966
43. Wang H.C., Chou W.C., Shieh S.Y., and Shen C.Y. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining. Cancer Res. 66 (2006) 1391-1400
44. Zhao S., Weng Y.C., Yuan S.S., Lin Y.T., Hsu H.C., Lin S.C., Gerbino E., Song M.H., Zdzienicka M.Z., Gatti R.A., Shay J.W., Ziv Y., Shiloh Y., and Lee E.Y. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405 (2000) 473-477
45. Zhuang J., Zhang J., Willers H., Wang H., Chung J.H., van Gent D.C., Hallahan D.E., Powell S.N., and Xia F. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res. 66 (2006) 1401-1408
46. Ariza R.R., Keyse S.M., Moggs J.G., and Wood R.D. Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts. Nucleic Acids Res. 24 (1996) 433-440
47. Coin F., Auriol J., Tapias A., Clivio P., Vermeulen W., and Egly J.M. Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity. EMBO J. 23 (2004) 4835-4846
48. Jans J., Schul W., Sert Y.G., Rijksen Y., Rebel H., Eker A.P., Nakajima S., van Steeg H., de Gruijl F.R., Yasui A., Hoeijmakers J.H., and van der Horst G.T. Powerful skin cancer protection by a CPD-photolyase transgene. Curr. Biol. 15 (2005) 105-115
49. Schul W., Jans J., Rijksen Y.M., Klemann K.H., Eker A.P., de Wit J., Nikaido O., Nakajima S., Yasui A., Hoeijmakers J.H., and van der Horst G.T. Enhanced repair of cyclobutane pyrimidine dimers and improved UV resistance in photolyase transgenic mice. EMBO J. 21 (2002) 4719-4729
50. Shell S.M., Li Z., Shkriabai N., Kvaratskhelia M., Brosey C., Serrano M.A., Chazin W.J., Musich P.R., and Zou Y. Checkpoint kinase ATR promotes nucleotide excision repair of UV-induced DNA damage via physical interaction with xeroderma pigmentosum group A. J. Biol. Chem. 284 (2009) 24213-24222